Gil Roth12.20.13
Phase II
FibroGen begins IPF trial enrollment . . . read more
MicuRx expands antibiotic program . . . read more
Ultragenyx posts topline results in HIBM trial . . . read more
Filings
Amarin sNDA review delayed . . . read more
Cellceutix files for Orphan designation for mucositis treatment . . . read more
Eliquis sNDA Accepted by FDA . . . read more
FibroGen begins IPF trial enrollment . . . read more
MicuRx expands antibiotic program . . . read more
Ultragenyx posts topline results in HIBM trial . . . read more
Filings
Amarin sNDA review delayed . . . read more
Cellceutix files for Orphan designation for mucositis treatment . . . read more
Eliquis sNDA Accepted by FDA . . . read more